MedDataX Logo

Qualitative Study on the Perception of Changes in the Psychotherapy of Traumatized Young People

NCT ID: NCT06138522

Last Updated: 2025-12-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

65 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-11-30

Study Completion Date

2028-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The clinic of psychological trauma in adolescents still requires further development, whereas it is well documented in adults. This clinic is complex, because it must take into account the nature and type of trauma (recent or not, intentional or not, situations of abuse or sexual violence, etc.), the impact on development, the contexts (social, cultural and family) in which the trauma occurs, and the various vulnerability factors associated with it. This complexity has implications for psychotherapeutic management, which needs to be tailored to the specific clinical profiles of adolescents.

Several studies have evaluated psychotherapy for traumatized adolescents, showing a positive short-term effect on the reduction of post-traumatic stress symptoms, whatever the type of psychotherapy. Few studies, however, have analyzed the therapeutic process and the common factors of change, linked mainly to the therapeutic alliance, the patient's experience and the therapist's role: key factors of change according to the international literature. In this context, the patient's experience of his or her psychotherapeutic follow-up is a source of information that has long been neglected, even though it seems essential for better investigating and understanding the complexity of the processes at play in trauma psychotherapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The clinic of psychological trauma in adolescents still requires further development, whereas it is well documented in adults. This clinic is complex, because it must take into account the nature and type of trauma (recent or not, intentional or not, situations of abuse or sexual violence, etc.), the impact on development, the contexts (social, cultural and family) in which the trauma occurs, and the various vulnerability factors associated with it. This complexity has implications for psychotherapeutic management, which needs to be tailored to the specific clinical profiles of adolescents.

Several studies have evaluated psychotherapy for traumatized adolescents, showing a positive short-term effect on the reduction of post-traumatic stress symptoms, whatever the type of psychotherapy. Few studies, however, have analyzed the therapeutic process and the common factors of change, linked mainly to the therapeutic alliance, the patient's experience and the therapist's role: key factors of change according to the international literature. In this context, the patient's experience of his or her psychotherapeutic follow-up is a source of information that has long been neglected, even though it seems essential for better investigating and understanding the complexity of the processes at play in trauma psychotherapy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-traumatic Stress Disorder

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Post-traumatic stress disorder Psychotherapy Qualitative study

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adolescents

Participants in consultations specialising in the treatment of psychotrauma at the Maison de Solenn

Semi-structured interviews

Intervention Type BEHAVIORAL

Semi-structured interviews

Child Post-Traumatic Stress Response Index (CPTS-RI) scale

Intervention Type BEHAVIORAL

Child Post-Traumatic Stress Response Index (CPTS-RI) scale

- Therapeutic Alliance Questionnaire (HAQ-CP)

Intervention Type BEHAVIORAL

\- Therapeutic Alliance Questionnaire (HAQ-CP)

Parents

Participants in consultations specialising in the treatment of psychotrauma at the Maison de Solenn

Semi-structured interviews

Intervention Type BEHAVIORAL

Semi-structured interviews

- Therapeutic Alliance Questionnaire (HAQ-CP)

Intervention Type BEHAVIORAL

\- Therapeutic Alliance Questionnaire (HAQ-CP)

Professionals

Participants in consultations specialising in the treatment of psychotrauma at the Maison de Solenn

- Therapeutic Alliance Questionnaire (HAQ-CP)

Intervention Type BEHAVIORAL

\- Therapeutic Alliance Questionnaire (HAQ-CP)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Semi-structured interviews

Semi-structured interviews

Intervention Type BEHAVIORAL

Child Post-Traumatic Stress Response Index (CPTS-RI) scale

Child Post-Traumatic Stress Response Index (CPTS-RI) scale

Intervention Type BEHAVIORAL

- Therapeutic Alliance Questionnaire (HAQ-CP)

\- Therapeutic Alliance Questionnaire (HAQ-CP)

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Teenagers :

* Teenagers from 12 to 18 years old
* Post-traumatic stress disorder (DSM Criteria 5 Post-Traumatic Stress Disorder)
* Consultant at the Maison de Solenn (Maison des Adolescents)
* Affiliated to a social security scheme

Parents : parents of adolescents followed at the MDA and agreeing to participate in the study

Professionals: providing psychotherapeutic follow-up for adolescents at the MDa

Exclusion Criteria

* Refusal of the adolescent and/or his/her family (if applicable) to participate in the study,
* Adults (all groups combined): under guardianship or curatorship, under judicial protection
Minimum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

URC-CIC Paris Descartes Necker Cochin

OTHER

Sponsor Role collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sevan Minassian, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital Cochin, Maison des Adolescents - Youth Department, F-75014 Paris, France

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Cochin, Maison des Adolescents - Youth Department, F-75014 Paris, France

Paris, IDF, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sevan Minassian, MD

Role: CONTACT

Phone: 00 33 1 58 41 24 29

Email: [email protected]

Marie Benhammani

Role: CONTACT

Phone: 00 33 1 58 41 11 90

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sevan Minassian

Role: primary

Khadija Chahraoui

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-A01689-36

Identifier Type: OTHER

Identifier Source: secondary_id

APHP231046

Identifier Type: -

Identifier Source: org_study_id